古德曼咨询小组在AbbVie的股权增加了12.7%,现在拥有价值311万美元的股票。 Goodman Advisory Group boosted its stake in AbbVie by 12.7%, now owning shares worth $3.11 million.

古德曼咨询小组有限责任公司在第四季度将其在AbbVie公司的股份增加了12.7%,现在拥有17 500股,价值3 110 000美元。 Goodman Advisory Group LLC increased its holdings in AbbVie Inc. by 12.7% in the fourth quarter, now owning 17,500 shares valued at $3,110,000. AbbVie获得了“机动购买”共识评级,平均价格目标为21071美元。 AbbVie has received a "Moderate Buy" consensus rating and an average price target of $210.71. 制药公司提供自发免疫疾病、癌症和血液失调的治疗,包括Humira、Skyrizi、Rinvoq、Imbruvica和Venclexta/Venclyxto。 The pharmaceutical company offers treatments for autoimmune diseases, cancer, and blood disorders, including Humira, Skyrizi, Rinvoq, Imbruvica, and Venclexta/Venclyxto. 资本集团投资管理,PTE。 Capital Group Investment Management PTE. LTD和Alpha DNA投资管理有限公司减少了在AbbVie的股份,而商业银行则增加了其股份。 LTD. and Alpha DNA Investment Management LLC have reduced their stakes in AbbVie, while Commerce Bank has increased its holdings.